Identification | Back Directory | [Name]
S(+)-N,N-DIETHYL-N'([8ALPHA]-6-METHYLERGOLIN-8-YL)UREA | [CAS]
37686-84-3 | [Synonyms]
TDHL Teluron dironyl tergurid terguride S(+)-TERGURIDE R-(+)-TERGURIDE TRANS-DIHYDROLISURIDE 9,10a-Dihydrolisuride Ergoline, urea deriv. 9,10α-Dihydrolisuride (5R,8S,10R)-Terguride (+)-(5R,8S,10R)-Terguride 9,10-alpha-dihydrolisuride S(+)-TERGURIDE (5R, 8S, 10R) Indolo[4,3-fg]quinoline, urea deriv. 1,1-Diethyl-3-(6-methylergolin-8α-yl)urea 6-Methyl-8a-(diethylcarbamoylamino)ergoline 6-Methyl-8α-(diethylcarbaMoylaMino)ergoline N,N-Diethyl-N'-[(8α)-6-Methylergolin-8-yl]urea Urea, N,N-diethyl-N'-[(8α)-6-methylergolin-8-yl]- s(+)-n,n-diethyl-n'([8α]-6-methylergolin-8-yl)urea N,N-Diethyl-N'-(D-6-methyl-10a-isoergolin-8-yl)urea n,n-diethyl-n’-((8-alpha)-6-methylergolin-8-yl)-ure N,N-Diethyl-N'-(D-6-Methyl-10α-isoergolin-8-yl)urea 1-((5r,8s,10r)-6-methyl-8-ergolinyl)-3,3-diethylurea S(+)-N,N-DIETHYL-N'([8ALPHA]-6-METHYLERGOLIN-8-YL)UREA Urea, N,N-diethyl-N'-[(8a)-6-methylergolin-8-yl]- (9CI) S(+)-N,N-Diethyl-Nμ([8α]-6-methylergolin-8-yl)urea, S(+)-Terguride (5R, 8S, 10R) 1,1-Diethyl-3-((6aR,9S)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)urea | [EINECS(EC#)]
253-624-2 | [Molecular Formula]
C20H28N4O | [MDL Number]
MFCD00242729 | [MOL File]
37686-84-3.mol | [Molecular Weight]
340.46 |
Chemical Properties | Back Directory | [Melting point ]
203-204° (dec); mp 205-207° (dec) (Cerny) | [alpha ]
D20 +30° (c = 1 in pyridine); D20 +29.0° (c = 0.2 in pyridine) | [Boiling point ]
476.25°C (rough estimate) | [density ]
1.1056 (rough estimate) | [refractive index ]
1.6620 (estimate) | [storage temp. ]
2-8°C | [solubility ]
DMSO: soluble | [form ]
solid | [pka]
13.60±0.20(Predicted) | [color ]
white | [Stability:]
Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 2 months. |
Hazard Information | Back Directory | [Description]
Terguride (37686-84-3) is a semi-synthetic ergoline derivative which acts as a partial dopamine D2 agonist and 5HT2B/2C receptor antagonist. Displays antiparkinsonian effects in MPTP-treated cynomolgus monkeys.1?Partial agonist at recruitment of β-arrestin2 to the D2 receptor.2 Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats.3 | [Uses]
An ergot alkaloid derivative that acts as a partial dopamine D2-receptor agonist. An anti-hyperprolactinemia agent. | [Definition]
ChEBI: Terguride is an organic molecular entity. | [References]
1) Akai et al. (1993), Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys; Ann. Neurol., 133 507
2) Klewe et al. (2008), Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling; Neuropharmacology, 54 1215
3) Dumitrascu et al. (2011), Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats; Eur. Respir. J., 37 1104 |
|
Company Name: |
LGM Pharma
|
Tel: |
1-(800)-881-8210 |
Website: |
www.lgmpharma.com |
Company Name: |
Energy Chemical
|
Tel: |
021-58432009 400-005-6266 |
Website: |
http://www.energy-chemical.com |
|